REQUEST A DEMO
Total
USD $0.00
Search more companies

Pt Oncoprobe Utama (Indonesia)

Main Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Full name: Pt Oncoprobe Utama Profile Updated: November 14, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pt Oncoprobe Utama is based in Indonesia, with the head office in Central Jakarta. It operates in the Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers industry. It was established on July 20, 2000. There was a net sales revenue increase of 10.37% reported in Pt Oncoprobe Utama’s latest financial highlights for 2024. Its total assets grew by 14.1% over the same period.

Headquarters
Apartemen Istana Harmoni Lantai Dasar Unit 1-M, Kompleks Harmoni Plaza
Central Jakarta; Jakarta; Postal Code: 10130

Contact Details: Purchase the Pt Oncoprobe Utama report to view the information.

Website: http://www.oncoprobe.co.id

Basic Information
Registered Capital:
Purchase the Pt Oncoprobe Utama report to view the information.
Financial Auditors:
Purchase the Pt Oncoprobe Utama report to view the information.
Incorporation Date:
July 20, 2000
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Commissioner
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pt Oncoprobe Utama report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
10.37%
Total Operating Revenue
10.37%
Total Assets
14.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?